4th World ADC Asia Summit 2025 will bring together leaders in the fields to showcase novel ADC technologies and optimize clinical trial and manufacturing efficiency in Asia.
The 4th World ADC Asia Summit is the premier forum for Asia’s fast-growing antibody-drug conjugate (ADC) community. With billions in investments and global partnerships surging, this event covers discovery, preclinical, clinical, and CMC advancements. Key discussions include emerging clinical data, novel ADC designs, and strategic licensing—featuring insights from AstraZeneca, Daiichi Sankyo, and top Asian biotech leaders.
Find out more
